In a cohort of Sri Lankan women, XRCC2 c.*1772G > A (rs3218550) increased the risk of BC (OR = 1.525, 95% CI 1.107–2.101, p = 0.0098) (Sirisena et al. 2018). This evidence concerns the gene XRCC2 and breast cancer.